Quarterly report pursuant to Section 13 or 15(d)

SIGNIFICANT ACCOUNTING POLICIES (Details 5)

v3.22.1
SIGNIFICANT ACCOUNTING POLICIES (Details 5) - shares
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Convertible notes and accrued interest    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 7,616,305 8,906,773
Convertible Preferred Stock - Series B    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 0 1,181,818
Compensation Based Stock Options and Warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 44,688,591 19,220,714